Publication: Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
dc.contributor.author | Hedegaard, Jakob (59128418500) | |
dc.contributor.author | Lamy, Philippe (14523099800) | |
dc.contributor.author | Nordentoft, Iver (23135023200) | |
dc.contributor.author | Algaba, Ferran (7004938705) | |
dc.contributor.author | Høyer, Søren (7101695038) | |
dc.contributor.author | Ulhøi, Benedicte Parm (6508196859) | |
dc.contributor.author | Vang, Søren (8363524700) | |
dc.contributor.author | Reinert, Thomas (55307741600) | |
dc.contributor.author | Hermann, Gregers G. (7201685053) | |
dc.contributor.author | Mogensen, Karin (7005747632) | |
dc.contributor.author | Thomsen, Mathilde Borg Houlberg (56489796900) | |
dc.contributor.author | Nielsen, Morten Muhlig (36803572700) | |
dc.contributor.author | Marquez, Mirari (55844808700) | |
dc.contributor.author | Segersten, Ulrika (6507983017) | |
dc.contributor.author | Aine, Mattias (55246424800) | |
dc.contributor.author | Höglund, Mattias (55909480100) | |
dc.contributor.author | Birkenkamp-Demtröder, Karin (6508228269) | |
dc.contributor.author | Fristrup, Niels (26640391300) | |
dc.contributor.author | Borre, Michael (7003854479) | |
dc.contributor.author | Hartmann, Arndt (7402943612) | |
dc.date.accessioned | 2025-06-12T18:28:41Z | |
dc.date.available | 2025-06-12T18:28:41Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease with widely different outcomes. We performed a comprehensive transcriptional analysis of 460 early-stage urothelial carcinomas and showed that NMIBC can be subgrouped into three major classes with basal- and luminal-like characteristics and different clinical outcomes. Large differences in biological processes such as the cell cycle, epithelial-mesenchymal transition, and differentiation were observed. Analysis of transcript variants revealed frequent mutations in genes encoding proteins involved in chromatin organization and cytoskeletal functions. Furthermore, mutations in well-known cancer driver genes (e.g., TP53 and ERBB2) were primarily found in high-risk tumors, together with APOBEC-related mutational signatures. The identification of subclasses in NMIBC may offer better prognostication and treatment selection based on subclass assignment. © 2016 Elsevier Inc. | |
dc.identifier.uri | https://doi.org/10.1016/j.ccell.2016.05.004 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979732333&doi=10.1016%2fj.ccell.2016.05.004&partnerID=40&md5=1db6fdfc6398dcad7c05666a87f51088 | |
dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/7565 | |
dc.title | Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma | |
dspace.entity.type | Publication |